FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080663894> ?p ?o ?g. }

• W2080663894 endingPage "53" @default.
• W2080663894 startingPage "43" @default.
• W2080663894 abstract "In a recent investigation we found that hospitalized patients with cystic fibrosis who received 0.5 cc of 0.5% albuterol nebulizer solution TID significantly increased their pulmonary function across the day, but fell back to baseline overnight. To determine whether this fall could be prevented by the long-acting beta-2 agonist salmeterol at both standard (2 puffs: 42 mcg BID) and high (4 puffs, 84 mcg BID) doses, we evaluated the effects of salmeterol vs. albuterol (2 puffs, 180 mcg QID, and 4 puffs, 360 mcg BID) in a placebo-controlled three-way random crossover, double-blind trial. Eighteen patients in the low-dose group and 10 of the same 18 patients in the high-dose group completed the 3 consecutive days of testing and received either salmeterol, albuterol, or placebo with each of four chest physiotherapy sessions given at 7 am, 11 am, 3 pm, and 7 pm. At standard doses (2 puffs), the mean percent changes in FEV1 pre- to post-7 am therapy for salmeterol (5.5%) and albuterol (9.9%) were significantly greater than with placebo (−1.2%) (P < 0.05 and 0.01, respectively). The mean percent changes in FEV1 from morning baseline with salmeterol were also significantly greater than placebo before 3 pm (12.1% vs. 5.4%, P < 0.01), and neither albuterol nor salmeterol were significantly greater than placebo after 3 pm. At standard doses there was a significant carryover effect with salmeterol to the next morning for the FEV1 (7.3%) when compared to placebo (1.5%) and albuterol (−0.7%) (P < 0.05 and 0.05, respectively). At high doses (4 puffs), the mean percent change in FEV1 with pre- to post-7 am therapy increased to 22.7% and remained significantly greater than with placebo until pretherapy at 7 pm. The carryover effect the next morning was 14.7%. Salmeterol at 4 puffs compared favorably to albuterol nebulizer therapy given TID in both the incidence of responders for the FEV1 (70% vs. 71%) and the mean changes after therapy at 7 am (22.7% vs. 14.9%), and provided greater carryover effects to the next morning (14.7% vs. −0.7%), thus preventing the fall in pulmonary function back to baseline overnight. We recommend the use of high-dose salmeterol in hospitalized patients with FVC values of 40% of predicted or greater, starting with 2 and increasing to 4 puffs BID as tolerated. Pediatr Pulmonol. 1999; 27:43–53. © 1999 Wiley-Liss, Inc." @default.
• W2080663894 created "2016-06-24" @default.
• W2080663894 creator A5027476006 @default.
• W2080663894 creator A5045133154 @default.
• W2080663894 creator A5080763714 @default.
• W2080663894 creator A5089784618 @default.
• W2080663894 date "1999-01-01" @default.
• W2080663894 modified "2023-10-14" @default.
• W2080663894 title "Effects of standard and high doses of salmeterol on lung function of hospitalized patients with cystic fibrosis" @default.
• W2080663894 cites W1882511742 @default.
• W2080663894 cites W1932396143 @default.
• W2080663894 cites W1972202183 @default.
• W2080663894 cites W1987666722 @default.
• W2080663894 cites W2007709488 @default.
• W2080663894 cites W2020034766 @default.
• W2080663894 cites W2032984244 @default.
• W2080663894 cites W2043224247 @default.
• W2080663894 cites W2058542513 @default.
• W2080663894 cites W2062646622 @default.
• W2080663894 cites W2071398272 @default.
• W2080663894 cites W2080423498 @default.
• W2080663894 cites W2082968284 @default.
• W2080663894 cites W2084675078 @default.
• W2080663894 cites W2086047595 @default.
• W2080663894 cites W2091536286 @default.
• W2080663894 cites W2094395573 @default.
• W2080663894 cites W2100013950 @default.
• W2080663894 cites W2110807723 @default.
• W2080663894 cites W2112434688 @default.
• W2080663894 doi "https://doi.org/10.1002/(sici)1099-0496(199901)27:1<43::aid-ppul9>3.0.co;2-e" @default.
• W2080663894 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10023791" @default.
• W2080663894 hasPublicationYear "1999" @default.
• W2080663894 type Work @default.
• W2080663894 sameAs 2080663894 @default.
• W2080663894 citedByCount "26" @default.
• W2080663894 countsByYear W20806638942012 @default.
• W2080663894 countsByYear W20806638942014 @default.
• W2080663894 countsByYear W20806638942016 @default.
• W2080663894 countsByYear W20806638942017 @default.
• W2080663894 countsByYear W20806638942018 @default.
• W2080663894 countsByYear W20806638942021 @default.
• W2080663894 countsByYear W20806638942023 @default.
• W2080663894 crossrefType "journal-article" @default.
• W2080663894 hasAuthorship W2080663894A5027476006 @default.
• W2080663894 hasAuthorship W2080663894A5045133154 @default.
• W2080663894 hasAuthorship W2080663894A5080763714 @default.
• W2080663894 hasAuthorship W2080663894A5089784618 @default.
• W2080663894 hasConcept C126322002 @default.
• W2080663894 hasConcept C142724271 @default.
• W2080663894 hasConcept C19720800 @default.
• W2080663894 hasConcept C204787440 @default.
• W2080663894 hasConcept C27081682 @default.
• W2080663894 hasConcept C2776042228 @default.
• W2080663894 hasConcept C2776719499 @default.
• W2080663894 hasConcept C2776954882 @default.
• W2080663894 hasConcept C2777394947 @default.
• W2080663894 hasConcept C2780352487 @default.
• W2080663894 hasConcept C2781018748 @default.
• W2080663894 hasConcept C42219234 @default.
• W2080663894 hasConcept C71924100 @default.
• W2080663894 hasConcept C75603125 @default.
• W2080663894 hasConcept C87813604 @default.
• W2080663894 hasConceptScore W2080663894C126322002 @default.
• W2080663894 hasConceptScore W2080663894C142724271 @default.
• W2080663894 hasConceptScore W2080663894C19720800 @default.
• W2080663894 hasConceptScore W2080663894C204787440 @default.
• W2080663894 hasConceptScore W2080663894C27081682 @default.
• W2080663894 hasConceptScore W2080663894C2776042228 @default.
• W2080663894 hasConceptScore W2080663894C2776719499 @default.
• W2080663894 hasConceptScore W2080663894C2776954882 @default.
• W2080663894 hasConceptScore W2080663894C2777394947 @default.
• W2080663894 hasConceptScore W2080663894C2780352487 @default.
• W2080663894 hasConceptScore W2080663894C2781018748 @default.
• W2080663894 hasConceptScore W2080663894C42219234 @default.
• W2080663894 hasConceptScore W2080663894C71924100 @default.
• W2080663894 hasConceptScore W2080663894C75603125 @default.
• W2080663894 hasConceptScore W2080663894C87813604 @default.
• W2080663894 hasIssue "1" @default.
• W2080663894 hasLocation W20806638941 @default.
• W2080663894 hasLocation W20806638942 @default.
• W2080663894 hasOpenAccess W2080663894 @default.
• W2080663894 hasPrimaryLocation W20806638941 @default.
• W2080663894 hasRelatedWork W1966364214 @default.
• W2080663894 hasRelatedWork W2019235998 @default.
• W2080663894 hasRelatedWork W2020192336 @default.
• W2080663894 hasRelatedWork W2080663894 @default.
• W2080663894 hasRelatedWork W2101710269 @default.
• W2080663894 hasRelatedWork W2136076889 @default.
• W2080663894 hasRelatedWork W2147412968 @default.
• W2080663894 hasRelatedWork W2400583725 @default.
• W2080663894 hasRelatedWork W2412563583 @default.
• W2080663894 hasRelatedWork W2465680215 @default.
• W2080663894 hasVolume "27" @default.
• W2080663894 isParatext "false" @default.
• W2080663894 isRetracted "false" @default.
• W2080663894 magId "2080663894" @default.
• W2080663894 workType "article" @default.